Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis
Article
[키워드] 95% confidence interval
Adults
adverse event
AEs
analyzed
booster
caused
Cochrane Library
control group
control groups
Controlled trial
coronavirus disease
Coverage
COVID-19
COVID-19 vaccination
COVID-19 vaccine
COVID-19 vaccines
DNA vaccines
dose
Efficacy
eligible
Factor
Factors
Fever
follow-up period
geometric mean titer
GMT
Health
highest
immunogenicity
inactivated
incidence
Increased
Local
Meta-analysis
meta-regression analysis
mRNA vaccine
Neutralizing antibodies
Older
older adult
Older adults
outcome
Pain
provided
random-effect
Randomized controlled trial
randomized controlled trials (RCTs)
Registered
required
Research
risk
Safety.
searched
seroconversion rate
severe disease
significantly increased
SMD
standardized mean difference
Strains
Surveillance
susceptible
systematic review
systemic AEs
Universal
vaccination
Vaccine
variant
Web of Science
[DOI] 10.3389/fimmu.2022.965971 PMC 바로가기
[DOI] 10.3389/fimmu.2022.965971 PMC 바로가기